Cooper Companies (NASDAQ:COO) Lowered to "Hold" Rating by Wall Street Zen

Key Points

• Wall Street Zen downgraded Cooper Companies to “Hold” from “Buy,” joining a broader cautious analyst consensus. The stock has an average “Hold” rating and an average price target of $71.47, with several firms recently cutting targets.
• Cooper Companies beat quarterly EPS estimates with $1.15 per share versus $1.12 expected, but revenue of $1.07 billion fell short of consensus. Management issued fiscal 2026 EPS guidance of $4.51–$4.55, contributing to concerns about near-term growth.
• The board authorized a $3 billion share-repurchase program, allowing buybacks of up to 22.7% of outstanding shares. However, the stock opened at $53.91, near its 52-week low of $51.01 and well below its 52-week high of $89.83.

Cooper Companies (NASDAQ:COO - Get Free Report) was downgraded by stock analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a note issued to investors on Saturday, Wall Street Zen reports.

Other research analysts also recently issued research reports about the company. Citigroup reissued a "neutral" rating and set a $60.00 target price (down from $80.00) on shares of Cooper Companies in a research note on Thursday. UBS Group reduced their price target on shares of Cooper Companies from $75.00 to $66.00 and set a "neutral" rating on the stock in a research note on Thursday. Robert W. Baird set a $61.00 price target on shares of Cooper Companies and gave the company a "neutral" rating in a report on Thursday. Bank of America reiterated a "neutral" rating and set a $65.00 price objective (down from $80.00) on shares of Cooper Companies in a research report on Thursday. Finally, Mizuho set a $75.00 price objective on shares of Cooper Companies and gave the company an "outperform" rating in a research note on Thursday. Five investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $71.47.

Cooper Companies Stock Down 0.5%

NASDAQ COO opened at $53.91 on Friday. The business has a fifty day moving average price of $71.62 and a two-hundred day moving average price of $69.70. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 0.78. Cooper Companies has a fifty-two week low of $51.01 and a fifty-two week high of $89.83. The stock has a market capitalization of $10.51 billion, a PE ratio of 18.40, a PEG ratio of 1.45 and a beta of 0.82.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Wednesday, September 9th. The medical device company reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $1.12 by $0.03. Cooper Companies had a return on equity of 10.90% and a net margin of 13.46%.The firm had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.10 billion. During the same quarter last year, the business posted $0.49 EPS. The company's revenue was up .5% compared to the same quarter last year. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. Equities analysts expect that Cooper Companies will post 4.53 earnings per share for the current fiscal year.

Cooper Companies declared that its board has approved a stock repurchase plan on Wednesday, September 9th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the medical device company to repurchase up to 22.7% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's management believes its shares are undervalued.

Institutional Trading of Cooper Companies

Several hedge funds and other institutional investors have recently made changes to their positions in COO. Sequoia Financial Advisors LLC increased its stake in shares of Cooper Companies by 290.4% in the second quarter. Sequoia Financial Advisors LLC now owns 34,286 shares of the medical device company's stock valued at $2,459,000 after buying an additional 25,504 shares during the period. Tidal Investments LLC boosted its position in Cooper Companies by 281.4% during the 2nd quarter. Tidal Investments LLC now owns 82,903 shares of the medical device company's stock worth $5,945,000 after buying an additional 61,165 shares during the period. National Pension Service grew its holdings in Cooper Companies by 9,314.0% during the 2nd quarter. National Pension Service now owns 526,149 shares of the medical device company's stock worth $37,730,000 after acquiring an additional 520,560 shares during the last quarter. WINTON GROUP Ltd grew its holdings in Cooper Companies by 379.0% during the 2nd quarter. WINTON GROUP Ltd now owns 42,483 shares of the medical device company's stock worth $3,046,000 after acquiring an additional 33,613 shares during the last quarter. Finally, Engineers Gate Manager LP grew its holdings in Cooper Companies by 8,637.7% during the 2nd quarter. Engineers Gate Manager LP now owns 249,897 shares of the medical device company's stock worth $17,920,000 after acquiring an additional 247,037 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors.

Trending Headlines about Cooper Companies

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Cooper reported adjusted fiscal Q3 earnings of $1.15 per share, ahead of the approximately $1.11–$1.12 consensus, with earnings up from $0.49 a year earlier. Cost controls and continued fertility-related growth helped offset weakness elsewhere. Cooper Companies Bets on Fertility Growth Despite Weakness in CooperVision
• Positive Sentiment: The board authorized an additional $1 billion of repurchases, bringing the total buyback authorization to $3 billion. The program could support per-share earnings and signal management believes COO shares are undervalued. Cooper Outlines Q4 EPS and Adds to Buyback Authorization
• Neutral Sentiment: Cooper completed a strategic review but chose not to pursue a sale or separate transaction for CooperSurgical. Keeping the business preserves its fertility-growth opportunity, but investors had apparently anticipated a potential deal or value-unlocking action. Cooper Cos. Stock Drops After Soft Outlook and No Deal
• Negative Sentiment: Revenue rose only about 1% to $1.066 billion, missing the roughly $1.10 billion consensus. U.S. channel destocking and inventory reductions pressured CooperVision, raising concerns about near-term demand and sales momentum. COO Q3 Earnings Top Estimates, Revenues Miss on Destocking
• Negative Sentiment: Management reduced fiscal 2026 earnings guidance to $4.51–$4.55 per share and issued fourth-quarter guidance of $1.05–$1.09, below prior expectations. The weaker outlook triggered multiple analyst downgrades and price-target cuts, including from Baird, UBS, JPMorgan and William Blair.
• Negative Sentiment: Law firms have announced securities-fraud investigations connected with the post-earnings decline. These notices are often promotional, but they add to negative investor sentiment and potential legal uncertainty. Securities Fraud Investigation Into Cooper Companies Announced

Cooper Companies Company Profile

Cooper Companies, Inc is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company develops, manufactures and markets products through two primary business segments: CooperVision and CooperSurgical.

CooperVision specializes in contact lenses, including daily disposable, toric, multifocal, multifocal toric, specialty and myopia-management lenses. Its products are designed to address a range of vision-correction needs, including astigmatism, presbyopia and irregular corneas.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.